Search





Search





Markets
/
Stocks
/
nxtc
/

NextCure Inc

NXTC

Add to Watchlist

4.145USD

-0.885-17.59%

Close 07-31 16:00（ET）Quotes delayed by 15 min

14.95MMarket Cap

LossP/E TTM

NextCure Inc

4.145

-0.885-17.59%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

NXTC Cash Flow Statement

You can access the annual and quarterly cash flow statements of NextCure Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-2.84%-13.36M

-9.60%-7.64M

45.28%-6.27M

-132.33%-22.71M

-3.08%-12.99M

34.69%-6.97M

10.36%-11.45M

33.71%-9.78M

14.70%-12.61M

-19.23%-10.67M

14.82%-12.78M

-1.78%-14.75M

4.32%-14.78M

33.65%-8.95M

-18.47%-15.00M

15.87%-14.49M

-11.04%-15.45M

-114.85%-13.49M

19.21%-12.66M

-38.79%-17.22M

-31.31%-13.91M

37.16%-6.28M

-97.22%-15.67M

-17.01%-12.41M

-49.63%-10.59M

-144.46%-9.99M

-68.40%-7.95M

-113.94%-10.61M

-47.41%-7.08M

--22.47M

---4.72M

---4.96M

---4.80M

Net income from continuing operations

10.75%-9.80M

18.68%-9.44M

25.27%-8.62M

-74.03%-26.81M

35.84%-10.98M

19.80%-11.60M

19.31%-11.54M

13.75%-15.40M

-6.28%-17.11M

16.38%-14.47M

24.38%-14.30M

0.34%-17.86M

21.87%-16.10M

-2.13%-17.30M

-5.47%-18.91M

0.37%-17.92M

-24.61%-20.60M

-9.56%-16.94M

-9.55%-17.93M

-23.98%-17.99M

-269.87%-16.53M

-41.49%-15.46M

-94.06%-16.37M

-76.47%-14.51M

258.13%9.73M

-59.24%-10.93M

-47.71%-8.43M

-57.16%-8.22M

-23.20%-6.16M

---6.86M

---5.71M

---5.23M

---5.00M

Operating gains losses

-56.73%283.00K

-45.85%365.00K

-23.86%533.00K

-9.57%633.00K

-74.62%654.00K

-18.20%674.00K

-26.00%700.00K

-26.62%700.00K

168.44%2.58M

-18.17%824.00K

-7.35%946.00K

--954.00K

-54.22%960.00K

--1.01M

-51.29%1.02M

----

89.77%2.10M

----

136.84%2.10M

140.41%1.89M

47.14%1.10M

31.13%990.00K

12.31%885.00K

35.22%787.00K

33.39%751.00K

45.75%755.00K

98.99%788.00K

50.39%582.00K

49.73%563.00K

--518.00K

--396.00K

--387.00K

--376.00K

Other non-cash items

200.00%95.00K

170.83%102.00K

152.31%102.00K

88.46%-3.00K

68.75%-95.00K

18.64%-144.00K

-12.07%-195.00K

59.38%-26.00K

-231.03%-304.00K

-121.88%-177.00K

-125.29%-174.00K

-103.36%-64.00K

--232.00K

-61.53%809.00K

--688.00K

--1.91M

----

--2.10M

----

Change in working capital

-8.86%-4.29M

-65.34%896.00K

157.55%1.12M

-18.03%2.88M

-1123.38%-3.94M

121.70%2.58M

-55.84%-1.95M

3518.56%3.51M

119.71%385.00K

-71.71%1.17M

-1026.13%-1.25M

113.55%97.00K

-554.19%-1.95M

454.73%4.12M

-116.11%-111.00K

81.71%-716.00K

143.39%430.00K

-119.87%-1.16M

126.88%689.00K

-347.31%-3.91M

95.51%-991.00K

1615.28%5.85M

-210.67%-2.56M

74.10%-875.00K

-1080.44%-22.09M

-101.35%-386.00K

-263.37%-825.00K

-2365.69%-3.38M

-803.86%-1.87M

--28.69M

--505.00K

---137.00K

---207.00K

-Change in prepaid expenses

-285.54%-308.00K

-16.77%1.62M

167.94%1.20M

-176.07%-1.88M

107.87%166.00K

88.22%1.95M

109.39%446.00K

295.73%2.47M

-293.66%-2.11M

-42.57%1.04M

169.61%213.00K

-1480.00%-1.26M

75.65%1.09M

420.43%1.80M

-244.34%-306.00K

98.14%-80.00K

317.54%620.00K

-145.08%-563.00K

244.22%212.00K

-273.54%-4.29M

-147.03%-285.00K

309.92%1.25M

82.60%-147.00K

40.09%-1.15M

167.56%606.00K

-950.00%-595.00K

-3480.00%-845.00K

-2423.68%-1.92M

-2260.53%-897.00K

--70.00K

--25.00K

---76.00K

---38.00K

-Change in other current liabilities

-12.13%-305.00K

-11.61%-298.00K

-23.08%-288.00K

-32.39%-282.00K

-32.04%-272.00K

-32.84%-267.00K

-20.00%-234.00K

8.97%-213.00K

-47.14%-206.00K

-770.00%-201.00K

-9850.00%-195.00K

-1014.29%-234.00K

-1172.73%-140.00K

-84.04%30.00K

133.33%2.00K

-320.00%-21.00K

-100.73%-11.00K

1466.67%188.00K

-103.05%-6.00K

-111.63%-5.00K

106.78%1.51M

101.00%12.00K

118.19%197.00K

104.77%43.00K

-2500.00%-22.28M

-104.50%-1.20M

-3194.29%-1.08M

-2477.14%-902.00K

---857.00K

--26.68M

--35.00K

---35.00K

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-2.84%-13.36M

-9.60%-7.64M

45.28%-6.27M

-132.33%-22.71M

-3.08%-12.99M

34.69%-6.97M

10.36%-11.45M

33.71%-9.78M

14.70%-12.61M

-19.23%-10.67M

14.82%-12.78M

-1.78%-14.75M

4.32%-14.78M

33.65%-8.95M

-18.47%-15.00M

15.87%-14.49M

-11.04%-15.45M

-114.85%-13.49M

19.21%-12.66M

-38.79%-17.22M

-31.31%-13.91M

37.16%-6.28M

-97.22%-15.67M

-17.01%-12.41M

-49.63%-10.59M

-144.46%-9.99M

-68.40%-7.95M

-113.94%-10.61M

-47.41%-7.08M

--22.47M

---4.72M

---4.96M

---4.80M

Investing cash flow

Net cash from continuing investing activities

----

-361.54%-34.00K

-39.07%170.00K

7.50%301.00K

-85.08%37.00K

-98.50%13.00K

-47.56%279.00K

-32.37%280.00K

-18.69%248.00K

4.85%865.00K

-4.32%532.00K

94.37%414.00K

-60.18%305.00K

-15.82%825.00K

-70.32%556.00K

-92.48%213.00K

-46.99%766.00K

20.39%980.00K

282.24%1.87M

150.35%2.83M

54.55%1.45M

-57.25%814.00K

60.13%490.00K

191.75%1.13M

101.08%935.00K

--1.90M

--306.00K

--388.00K

--465.00K

Capital expenditures

----

-39.07%170.00K

7.50%301.00K

-85.08%37.00K

-98.50%13.00K

-47.56%279.00K

-32.37%280.00K

-18.69%248.00K

4.85%865.00K

-4.32%532.00K

94.37%414.00K

-60.18%305.00K

-15.82%825.00K

-70.32%556.00K

-92.48%213.00K

-46.99%766.00K

20.39%980.00K

282.24%1.87M

150.35%2.83M

54.55%1.45M

-57.25%814.00K

60.13%490.00K

191.75%1.13M

101.08%935.00K

--1.90M

--306.00K

--388.00K

--465.00K

Net cash flow from disposal of fixed assets

----

-361.54%-34.00K

-39.07%170.00K

7.50%301.00K

-85.08%37.00K

-98.50%13.00K

-47.56%279.00K

-32.37%280.00K

-18.69%248.00K

4.85%865.00K

-4.32%532.00K

94.37%414.00K

-60.18%305.00K

-15.82%825.00K

-70.32%556.00K

-92.48%213.00K

-46.99%766.00K

20.39%980.00K

282.24%1.87M

150.35%2.83M

54.55%1.45M

-57.25%814.00K

60.13%490.00K

191.75%1.13M

101.08%935.00K

--1.90M

--306.00K

--388.00K

--465.00K

Net cash flow from investment products

-81.67%1.30M

-13.30%6.00M

-52.91%8.70M

-69.83%3.76M

-60.41%7.09M

65.84%6.92M

75.02%18.48M

78.27%12.46M

-2.46%17.92M

-21.71%4.17M

-42.69%10.56M

-78.38%6.99M

31.15%18.37M

152.41%5.33M

23.05%18.42M

104.64%32.34M

-23.73%14.01M

-158.22%-10.18M

-0.04%14.97M

38.81%15.80M

169.38%18.37M

113.83%17.48M

108.60%14.98M

--11.38M

--6.82M

---126.35M

---174.21M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-81.67%1.30M

-13.73%6.00M

-52.48%8.70M

-69.09%3.76M

-60.33%7.09M

67.18%6.96M

78.12%18.31M

81.22%12.16M

-1.33%17.88M

-6.85%4.16M

-42.54%10.28M

-78.98%6.71M

32.26%18.12M

140.61%4.47M

24.10%17.89M

104.78%31.92M

-22.15%13.70M

-166.68%-11.00M

10.01%14.41M

82.34%15.59M

227.56%17.60M

112.97%16.50M

107.50%13.10M

855.21%8.55M

674.65%5.37M

-6578.62%-127.16M

-56989.87%-174.69M

-191.75%-1.13M

-101.08%-935.00K

---1.90M

---306.00K

---388.00K

---465.00K

Financing cash flow

Cash flow from continuous financing activities

--1.25M

56269.44%20.29M

-100.00%0.00

1804.72%2.02M

----

-49.30%36.00K

--1.00K

27.71%106.00K

--1.00K

16.39%71.00K

--0.00

5.06%83.00K

-100.00%0.00

-50.41%61.00K

100.00%0.00

119.55%79.00K

116.95%60.00K

130.90%123.00K

-624.52%-2.63M

2.42%-404.00K

-47.50%-354.00K

-100.25%-398.00K

-224.11%-363.00K

-100.52%-414.00K

-108.08%-240.00K

77.79%161.31M

1.75%-112.00K

155.27%78.88M

3070.00%2.97M

--90.73M

---114.00K

--30.90M

---100.00K

Net cash flow from debt Issuance/repayment

----

--0.00

100.00%0.00

-532.85%-2.64M

0.00%-417.00K

-50.54%-417.00K

---416.00K

---417.00K

-106.10%-277.00K

100.00%0.00

----

4640.00%4.54M

---100.00K

Net cash flow from common stock issuance/repurchase

----

--20.28M

--0.00

----

-2200.00%-63.00K

70.27%63.00K

-99.99%18.00K

145.45%54.00K

-100.00%3.00K

825.00%37.00K

4029250.00%161.17M

--22.00K

--77.30M

--4.00K

--0.00

Net cash flow from preferred stock issuance/repurchase

----

--0.00

--2.00M

----

-100.00%0.00

--0.00

-100.00%0.00

----

--91.22M

--0.00

--31.00M

----

Proceeds from stock option exercised by employees

--14.00K

-52.78%17.00K

-100.00%0.00

-71.64%19.00K

----

-49.30%36.00K

--1.00K

-19.28%67.00K

--1.00K

16.39%71.00K

--0.00

5.06%83.00K

-100.00%0.00

-50.41%61.00K

-100.00%0.00

3.95%79.00K

--60.00K

--123.00K

--9.00K

--76.00K

----

Net cash flow from other financing activities

--1.23M

--20.28M

--0.00

----

--0.00

--39.00K

----

100.00%0.00

----

100.00%0.00

133.84%134.00K

-857.14%-134.00K

--1.57M

---1.57M

---396.00K

---14.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--1.25M

56269.44%20.29M

-100.00%0.00

1804.72%2.02M

----

-49.30%36.00K

--1.00K

27.71%106.00K

--1.00K

16.39%71.00K

--0.00

5.06%83.00K

-100.00%0.00

-50.41%61.00K

100.00%0.00

119.55%79.00K

116.95%60.00K

130.90%123.00K

-624.52%-2.63M

2.42%-404.00K

-47.50%-354.00K

-100.25%-398.00K

-224.11%-363.00K

-100.52%-414.00K

-108.08%-240.00K

77.79%161.31M

1.75%-112.00K

155.27%78.88M

3070.00%2.97M

--90.73M

---114.00K

--30.90M

---100.00K

Net cash flow

Beginning cash balance

-6.29%25.98M

-73.56%7.32M

-76.53%4.89M

18.90%21.83M

111.95%27.73M

41.92%27.70M

-5.32%20.85M

-38.75%18.36M

-50.87%13.08M

-37.14%19.52M

-21.92%22.02M

180.36%29.97M

115.17%26.63M

-15.40%31.05M

-24.96%28.20M

-73.02%10.69M

-65.89%12.38M

38.70%36.70M

27.85%37.58M

17.67%39.62M

-7.27%36.28M

76.72%26.46M

-85.13%29.39M

-74.22%33.67M

-71.15%39.13M

-38.47%14.97M

570.86%197.73M

3232.18%130.59M

1360.46%135.63M

--24.34M

--29.47M

--3.92M

--9.29M

Current period cash flow changes

-83.31%-10.81M

74532.00%18.66M

-64.52%2.43M

-780.12%-16.93M

-211.83%-5.90M

100.39%25.00K

374.16%6.85M

131.31%2.49M

57.82%5.28M

-45.63%-6.44M

-186.60%-2.50M

-145.42%-7.95M

298.40%3.34M

81.86%-4.42M

428.82%2.89M

959.22%17.51M

-150.52%-1.69M

-348.08%-24.37M

70.06%-878.00K

52.32%-2.04M

161.07%3.33M

-59.34%9.82M

98.40%-2.93M

-106.37%-4.27M

-8.25%-5.46M

-78.30%24.16M

-3456.22%-182.75M

162.73%67.14M

6.02%-5.04M

--111.30M

---5.14M

--25.55M

---5.37M

Ending cash balance

-30.51%15.17M

-6.29%25.98M

-73.56%7.32M

-76.53%4.89M

18.90%21.83M

111.95%27.73M

41.92%27.70M

-5.32%20.85M

-38.75%18.36M

-50.87%13.08M

-37.22%19.52M

-21.92%22.02M

180.36%29.97M

115.85%26.63M

-15.30%31.09M

-24.96%28.20M

-73.02%10.69M

-66.00%12.34M

38.70%36.70M

27.85%37.58M

17.67%39.62M

-7.27%36.28M

76.72%26.46M

-85.13%29.39M

-74.22%33.67M

-71.15%39.13M

-38.47%14.97M

570.86%197.73M

3232.18%130.59M

--135.63M

--24.34M

--29.47M

--3.92M

Free cash flow

-2.84%-13.36M

-9.60%-7.64M

46.08%-6.27M

-125.39%-22.71M

-2.78%-12.99M

34.77%-6.97M

10.97%-11.62M

32.94%-10.08M

15.86%-12.64M

-8.85%-10.68M

15.94%-13.06M

-0.83%-15.03M

4.60%-15.03M

31.43%-9.81M

-17.51%-15.53M

14.52%-14.90M

-7.32%-15.75M

-97.20%-14.31M

24.67%-13.22M

-14.38%-17.43M

-21.91%-14.68M

32.83%-7.26M

-107.96%-17.55M

-29.87%-15.24M

-50.21%-12.04M

-152.54%-10.80M

-67.90%-8.44M

-119.59%-11.74M

-52.15%-8.02M

--20.57M

---5.03M

---5.34M

---5.27M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did NextCure Inc Generate?



NextCure Inc generated -49.61M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did NextCure Inc's Operating Cash Flow Change Year Over Year?



NextCure Inc's operating cash flow increased by -21.59% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has NextCure Inc's Financing Cash Flow Changed?



NextCure Inc used 22.31M in financing activities in the latest quarter.

What is free cash flow and why does it matter for NXTC?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was NextCure Inc’s free cash flow in the latest quarter?



Free cash flow was -49.61M reflecting a -20.19% change from the previous year.